IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crestline Management, L.P.

Q3 2025 Holdings

Filed 2025-11-14 | 3 holdings | $58.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$49.5M3,410,73285.3%
Sana Biotechnology Inc(SANA)COM799566104$6.5M1,820,93711.1%
8X8 Inc New(EGHT)COM282914100$2.1M990,5803.6%